1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Psoriasis Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Psoriasis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Tumor Necrosis Factor Inhibitor
  • 1.4.3 Interleukin Inhibitors
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Psoriasis Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Topicals
  • 1.5.3 Systemic
  • 1.5.4 Biologics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Psoriasis Drugs Market Perspective (2015-2026)
• 2.2 Global Psoriasis Drugs Growth Trends by Regions
  • 2.2.1 Psoriasis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Psoriasis Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Psoriasis Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Psoriasis Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Psoriasis Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Psoriasis Drugs Players by Market Size
  • 3.1.1 Global Top Psoriasis Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Psoriasis Drugs Market Concentration Ratio
  • 3.2.1 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Psoriasis Drugs Revenue in 2019
• 3.3 Psoriasis Drugs Key Players Head office and Area Served
• 3.4 Key Players Psoriasis Drugs Product Solution and Service
• 3.5 Date of Enter into Psoriasis Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Psoriasis Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Psoriasis Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Psoriasis Drugs Market Size by Application (2015-2020)
• 5.2 Global Psoriasis Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Psoriasis Drugs Market Size (2015-2020)
• 6.2 Psoriasis Drugs Key Players in North America (2019-2020)
• 6.3 North America Psoriasis Drugs Market Size by Type (2015-2020)
• 6.4 North America Psoriasis Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Psoriasis Drugs Market Size (2015-2020)
• 7.2 Psoriasis Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Psoriasis Drugs Market Size by Type (2015-2020)
• 7.4 Europe Psoriasis Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Psoriasis Drugs Market Size (2015-2020)
• 8.2 Psoriasis Drugs Key Players in China (2019-2020)
• 8.3 China Psoriasis Drugs Market Size by Type (2015-2020)
• 8.4 China Psoriasis Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Psoriasis Drugs Market Size (2015-2020)
• 9.2 Psoriasis Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Psoriasis Drugs Market Size by Type (2015-2020)
• 9.4 Japan Psoriasis Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Psoriasis Drugs Market Size (2015-2020)
• 10.2 Psoriasis Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Psoriasis Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Psoriasis Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Psoriasis Drugs Market Size (2015-2020)
• 11.2 Psoriasis Drugs Key Players in India (2019-2020)
• 11.3 India Psoriasis Drugs Market Size by Type (2015-2020)
• 11.4 India Psoriasis Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Psoriasis Drugs Market Size (2015-2020)
• 12.2 Psoriasis Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Psoriasis Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Psoriasis Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AbbVie
  • 13.1.1 AbbVie Company Details
  • 13.1.2 AbbVie Business Overview
  • 13.1.3 AbbVie Psoriasis Drugs Introduction
  • 13.1.4 AbbVie Revenue in Psoriasis Drugs Business (2015-2020))
  • 13.1.5 AbbVie Recent Development
• 13.2 Amgen
  • 13.2.1 Amgen Company Details
  • 13.2.2 Amgen Business Overview
  • 13.2.3 Amgen Psoriasis Drugs Introduction
  • 13.2.4 Amgen Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.2.5 Amgen Recent Development
• 13.3 Johnson & Johnson
  • 13.3.1 Johnson & Johnson Company Details
  • 13.3.2 Johnson & Johnson Business Overview
  • 13.3.3 Johnson & Johnson Psoriasis Drugs Introduction
  • 13.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.3.5 Johnson & Johnson Recent Development
• 13.4 Novartis
  • 13.4.1 Novartis Company Details
  • 13.4.2 Novartis Business Overview
  • 13.4.3 Novartis Psoriasis Drugs Introduction
  • 13.4.4 Novartis Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.4.5 Novartis Recent Development
• 13.5 Eli Lilly & Company
  • 13.5.1 Eli Lilly & Company Company Details
  • 13.5.2 Eli Lilly & Company Business Overview
  • 13.5.3 Eli Lilly & Company Psoriasis Drugs Introduction
  • 13.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.5.5 Eli Lilly & Company Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview
  • 13.6.3 AstraZeneca Psoriasis Drugs Introduction
  • 13.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Celgene Corporation
  • 13.7.1 Celgene Corporation Company Details
  • 13.7.2 Celgene Corporation Business Overview
  • 13.7.3 Celgene Corporation Psoriasis Drugs Introduction
  • 13.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.7.5 Celgene Corporation Recent Development
• 13.8 UCB
  • 13.8.1 UCB Company Details
  • 13.8.2 UCB Business Overview
  • 13.8.3 UCB Psoriasis Drugs Introduction
  • 13.8.4 UCB Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.8.5 UCB Recent Development
• 13.9 Merck
  • 13.9.1 Merck Company Details
  • 13.9.2 Merck Business Overview
  • 13.9.3 Merck Psoriasis Drugs Introduction
  • 13.9.4 Merck Revenue in Psoriasis Drugs Business (2015-2020)
  • 13.9.5 Merck Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Psoriasis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck

Market segment by Type, the product can be split into
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
Market segment by Application, split into
Topicals
Systemic
Biologics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America